A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

Stopped The sponsor withdrew support for the study before any patients were enrolled.

Conditions

• Cancer
• Neoplasms
• Tumors

Interventions

• DRUG: OSI-906 and Pemetrexed

Sponsor

Emory University

Collaborators

• [object Object]